Nucleic Acids Research · 2016 · 10 citations · 60 references
The MYC proto-oncogene is upregulated, often at the transcriptional level, in ∼80% of all cancers. MYC's promoter is governed by a higher order G-quadruplex (G4) structure in the NHE III<sub>1</sub> region. Under a variety of conditions, multiple isoforms have been described to form from the first four continuous guanine runs (G4<sub>1-4</sub>) predominating under the physiologically relevant supercoiled conditions. In the current study, short oligonucleotides complementing the 5'- and 3'-regions flanking the G4 have been connected by an abasic linker to form G4 clamps, varying both linker length and G4 isoform being targeted. Clamp A with an 18 Å linker was found to have marked affinity for its target isomer (G4<sub>1-4</sub>) over the other major structures (G4<sub>2-5</sub> and G4<sub>1-5</sub>, recognized by clamps B and C, respectively), and to be able to shift equilibrating DNA to foster greater G4 formation. In addition, clamp A, but not B or C, is able to modulate MYC promoter activity with a significant and dose-dependent effect on transcription driven by the Del4 plasmid. This linked clamp-mediated approach to G4 recognition represents a novel therapeutic mechanism with specificity for an individual promoter structure, amenable to a large array of promoters.
60
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake Delmore, Ghayas C. Issa, Madeleine E. Lemieux et al. · Cell · 2011 · 2.8K citations · Full text
Quantitative visualization of DNA G-quadruplex structures in human cells
Giulia Biffi, David Tannahill, John McCafferty et al. · Nature Chemistry · 2013 · 2.1K citations · Full text
Chromatin, Dna, Cell Division +9
Modelling Myc inhibition as a cancer therapy
Laura Soucek, Jonathan R. Whitfield, Carla P. Martins et al. · Nature · 2008 · 805 citations · Full text